115 related articles for article (PubMed ID: 34816662)
1. [Effects of Magnolol combined with Gefitinib on A549 non-small cell lung cancer cells].
Ren JL; Cui LZ; Hao XX; Li XY; Chang YX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Sep; 37(5):506-510. PubMed ID: 34816662
[No Abstract] [Full Text] [Related]
2. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M
Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938
[TBL] [Abstract][Full Text] [Related]
3. [Gefitinib inhibits glycolysis and induces programmed cell death in non-small cell lung cancer cells].
Zhou Q; Li J; Pang J; Fan F; Li S; Liu H
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):884-892. PubMed ID: 32895203
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Fuzheng Kang'ai Recipe Combined Gefitinib on Lung Cancer A549 Cells and Its Mecha- nism Research].
Yang XB; Chen X; Wu WY; Long SQ; Chen SM; Han SW
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Nov; 36(11):1340-1344. PubMed ID: 30641628
[TBL] [Abstract][Full Text] [Related]
5. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L
Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Magnolol on Proliferation and Apoptosis of HL-60 Cells and Its Molecular Mechanism].
Fang K; Yuan XF; Liao Q; Zhang ZY; Song GH; Guo Q; Ren X; Jiang GS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):388-93. PubMed ID: 27150997
[TBL] [Abstract][Full Text] [Related]
7. Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells.
Tsai JR; Chong IW; Chen YH; Hwang JJ; Yin WH; Chen HL; Chou SH; Chiu CC; Liu PL
Arch Pharm Res; 2014 Apr; 37(4):548-57. PubMed ID: 23943503
[TBL] [Abstract][Full Text] [Related]
8. Anticancer potential of magnolol for lung cancer treatment.
Seo JU; Kim MH; Kim HM; Jeong HJ
Arch Pharm Res; 2011 Apr; 34(4):625-33. PubMed ID: 21544728
[TBL] [Abstract][Full Text] [Related]
9. Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells.
Lee YC; Weng YS; Wang HY; Hsu FT; Chueh FS; Wu JY; Chen WL; Chen JH
Anticancer Res; 2022 Aug; 42(8):3825-3833. PubMed ID: 35896265
[TBL] [Abstract][Full Text] [Related]
10. [FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer].
Peng C; Li P; Yang M; Chen D; Huang Y
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):538-547. PubMed ID: 34334155
[TBL] [Abstract][Full Text] [Related]
11. Magnolol-induced H460 cells death via autophagy but not apoptosis.
Li HB; Yi X; Gao JM; Ying XX; Guan HQ; Li JC
Arch Pharm Res; 2007 Dec; 30(12):1566-74. PubMed ID: 18254244
[TBL] [Abstract][Full Text] [Related]
12. Magnolol inhibits tumor necrosis factor-α-induced ICAM-1 expression via suppressing NF-κB and MAPK signaling pathways in human lung epithelial cells.
Chunlian W; Heyong W; Jia X; Jie H; Xi C; Gentao L
Inflammation; 2014 Dec; 37(6):1957-67. PubMed ID: 24893579
[TBL] [Abstract][Full Text] [Related]
13. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.
Sun C; Gao W; Liu J; Cheng H; Hao J
Respir Res; 2020 Aug; 21(1):210. PubMed ID: 32778129
[TBL] [Abstract][Full Text] [Related]
14. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
15. Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells.
Woo SM; Min KJ; Kwon TK
Molecules; 2020 Oct; 25(19):. PubMed ID: 33050112
[TBL] [Abstract][Full Text] [Related]
16. Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.
Chilampalli C; Guillermo R; Zhang X; Kaushik RS; Young A; Zeman D; Hildreth MB; Fahmy H; Dwivedi C
BMC Cancer; 2011 Oct; 11():456. PubMed ID: 22014088
[TBL] [Abstract][Full Text] [Related]
17. [Effects of shRNA on Cisplatin-resistant Non-small Cell Lung Cancer Cell A549 via Silencing
He L; Du ZD; Wang Y; Meng RQ; Zhao WW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):312-319. PubMed ID: 32543135
[TBL] [Abstract][Full Text] [Related]
18. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.
Gong J; He L; Ma J; Zhang J; Wang L; Wang J
J BUON; 2017; 22(2):454-461. PubMed ID: 28534369
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Magnolol Anticancer Potential in MKN-45 Gastric Cancer Cells.
Naghashpour M; Dayer D; Karami H; Naghashpour M; Moghadam MT; Haeri SMJ; Suzuki K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837487
[No Abstract] [Full Text] [Related]
20. Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K/Akt signaling pathways.
Rasul A; Yu B; Khan M; Zhang K; Iqbal F; Ma T; Yang H
Int J Oncol; 2012 Apr; 40(4):1153-61. PubMed ID: 22139054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
